2025 HCPCS Code J9063
Injection, mirvetuximab soravtansine-gynx, 1 mg
TAGS: mirvetuximab| Short Description | Inj, elahere, 1 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | July 01, 2023 |
| HCPCS Action Effective Date | July 01, 2023 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J1170 - Hydromorphone injection
- J1180 - Dyphylline injection
- J1190 - Dexrazoxane hcl injection
- J1200 - Diphenhydramine hcl injectio
- J1201 - Inj. cetirizine hcl 0.5mg
- J1202 - Miglustat oral 65 mg
- J1203 - Inj, cipaglucosidase, 5 mg
- J1205 - Chlorothiazide sodium inj
- J1212 - Dimethyl sulfoxide 50% 50 ml
- J1230 - Methadone injection
- J1240 - Dimenhydrinate injection
- J1245 - Dipyridamole injection
- J1250 - Inj dobutamine hcl/250 mg
- J1260 - Dolasetron mesylate
- J1265 - Dopamine injection
- J1267 - Doripenem injection
- J1270 - Injection, doxercalciferol
- J1290 - Ecallantide injection
- J1300 - Eculizumab injection
- J1301 - Injection, edaravone, 1 mg